Wednesday, March 15, 2006
© Copyright 2013
Gwinnett Daily Post
LAWRENCEVILLE - Biotechnology company Serologicals Corp. is expanding.
Norcross-based Serologicals plans to acquire the British company Cytomyx Ltd., whose parent company is Cytomyx Holdings. Cytomyx is a leading provider of ion channel cell lines and drug discovery services, which can help companies like Serologicals develop pharmaceuticals that won't cause toxic reactions in the body. Serologicals will use the Cytomyx acquisition to "further strengthen our capabilities within the drug discovery market by enabling our research segment to offer pharmaceutical and biotechnology companies the largest portfolio of ion channel cell lines commercially available today," CEO David Dodd said. Serologicals employs about 1,000 workers worldwide, including 100 at its Peachtree Corners headquarters.More like this story
- Gwinnett bioscience business sold to Mass. company ( April 26, 2006 )
- Rock-Tenn to acquire paper company ( April 29, 2005 )
- Gwinnett Tech offers classes for teachers in new technology ( June 14, 2007 )
- Week in Review: Serologicals sold to firm from Mass. ( April 30, 2006 )
- 12 Gwinnett companies among fastest revenue growth list ( October 13, 2006 )
Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment